SunBio선바이오
067370 · KOSDAQ · ₩067370 · 선바이오
- Market cap
- ₩69B
- Enterprise value
- ₩94B
- P/E
- 15.9×
- P/B
- 2.3×
- Dividend yield
- 0.0%
- ROE
- 14.4%
- Net margin
- 34.6%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−33.9% from the high
₩4,840Today: ₩5,350 – ₩5,630₩8,500
Returns
- 1W−3.4%
- 1M−0.4%
- 3M−4.7%
- 6M−31.6%
- YTD−1.1%
- 1Y−1.6%
- Volume today
- 8,525
- 0.9× the 20-day average
- Traded today
- ₩47M
- Listed shares
- 12,213,841
- EPS (12 months)
- ₩353
- Earnings yield 6.3%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 43 of 100 (50 is a normal day for this stock).
- MomentumFlat-0.7% over the last month; the price is above its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
SunBio stock overview
SunBio (선바이오, KRX: 067370) is listed on KOSDAQ, in the Biotech & Pharma sector. The company develops and manufactures polyethylene glycol (PEG) derivative materials, which it sells to customers in Korea and abroad, with sales to roughly 50 companies. Its shares closed at ₩5,620 on Oct 27, 2026, down 0.18% on the day, giving it a market value of ₩69B.
Key facts
- Market cap
- ₩69B
- Sector
- Biotech & Pharma
- Latest price change
- −0.18%
- As of
- Oct 27, 2026
- Main business
- The company develops and manufactures polyethylene glycol (PEG) derivative materials, which it sells to customers in Korea and abroad, with sales to roughly 50 companies.
Quick answers about SunBio
- What does SunBio do?
- The company develops and manufactures polyethylene glycol (PEG) derivative materials, which it sells to customers in Korea and abroad, with sales to roughly 50 companies. It also develops PEGylation-based drugs and technologies, including the pegfilgrastim biosimilar for neutropenia (sold in Europe, Canada, Australia, Mexico and India through partner Intas Pharma), the MucoPEG dry mouth treatment, an artificial blood project, and solid electrolyte research for lithium secondary batteries. The company operates from its headquarters and new GMP plant in Incheon Namdong Industrial Complex, Korea.
- What is the market cap of SunBio?
- The market capitalisation of SunBio was ₩69B at the close on Oct 27, 2026.
- Who are the largest shareholders of SunBio?
- According to the latest official filings, the largest reported holders are No Gwang (26.30%, as of Jun 9, 2026).
- When is the next earnings report from SunBio?
- Korean companies rarely announce results dates in advance. Based on when SunBio filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.
Company profile
The company develops and manufactures polyethylene glycol (PEG) derivative materials, which it sells to customers in Korea and abroad, with sales to roughly 50 companies. It also develops PEGylation-based drugs and technologies, including the pegfilgrastim biosimilar for neutropenia (sold in Europe, Canada, Australia, Mexico and India through partner Intas Pharma), the MucoPEG dry mouth treatment, an artificial blood project, and solid electrolyte research for lithium secondary batteries. The company operates from its headquarters and new GMP plant in Incheon Namdong Industrial Complex, Korea.
Written by AI from the company's latest annual report.
- Korean name
- 선바이오
- Sector
- Biotech & Pharma
- Themes
- Biotech (new drugs)
- CEO
- 노광
- Founded
- Jun 1997
- Listed
- Oct 2022
- Listed shares
- 12,213,841
- Fiscal year ends
- Month 12
- Website
- www.sunbio.com
Similar companies
- Samsung Biologics207940 · ₩64T₩1,374,000−5.37%
- Celltrion068270 · ₩44T₩188,600−0.74%
- Alteogen196170 · ₩15T₩218,5000.00%
- Yuhan000100 · ₩5.9T₩80,000−2.08%
- SK biopharmaceuticals326030 · ₩5.9T₩74,900−1.19%
- HLB028300 · ₩5.3T₩39,900+1.66%
- Hanmi Pharm128940 · ₩4.5T₩350,500−0.57%
- SAM Chun Dang Pharm000250 · ₩4.4T₩187,600−0.69%
Recent filings
See allTitles in Korean until English translations are added.
Also known as: SunBio / 선바이오 / 067370 / KRX:067370
Source: KRX statistical information